4//SEC Filing
KNIGHT SUSAN E 4
Accession 0001209191-22-014663
CIK 0000924717other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:02 PM ET
Size
9.1 KB
Accession
0001209191-22-014663
Insider Transaction Report
Form 4
SURMODICS INCSRDX
KNIGHT SUSAN E
Director
Transactions
- Sale
Common Stock
2022-02-28$44.97/sh−4,366$196,332→ 30,196 total - Exercise/Conversion
Stock Option (right to buy)
2022-02-28−4,366→ 0 totalExercise: $20.18Exp: 2022-12-18→ Common Stock (4,366 underlying) - Exercise/Conversion
Common Stock
2022-02-28$20.18/sh+4,366$88,106→ 34,562 total
Footnotes (3)
- [F1]Reflects the weighted average price of 4,366 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 28, 2022 with sale prices ranging from $44.96 to $45.08 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The amount beneficially owned includes 13,203 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
- [F3]Fully vested.
Documents
Issuer
SURMODICS INC
CIK 0000924717
Entity typeother
Related Parties
1- filerCIK 0001183157
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:02 PM ET
- Size
- 9.1 KB